LifeTech Scientific, Yeahka share sales net HK$1.9bn

Jonathan Breen

December 04, 2020 07:45 am

biotech_microscope_drug_production_adobe_575x375_oct13 — Medical science laboratory. Concept of virus research | Alphaspirit/alphaspirit - stock.adobe.com

Medical device maker LifeTech Scientific Corp tapped the Hong Kong market for HK$930m ($120m) in fresh equity on Thursday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC Securities Credit Suisse Health and Biotech Equity China Citi Hong Kong SAR Asia Follow-ons and Rights Issues Asia Greater China Morgan Stanley Northeast Asia Asia Pacific ABBs-Block Trades Follow-ons and Rights issues Emerging Markets SRI

JB

Jonathan Breen

Equities editor GlobalCapital Asia